biocryst in trouble, page-2

This one's worse...

http://www.bloomberg.com/news/2011-01-13/biocryst-wants-to-extend-iv-flu-drug-study.html

"BioCryst said 20 percent of the patients experienced a serious side effect. The most common of those side effects were respiratory failure or distress, septic shock, and kidney failure. One patient experienced elevated levels of liver enzymes. The company said 8.7 percent of patients died within four weeks of treatment, but no deaths were attributed to peramivir."